Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
AusCann logo — Cannabinoids-based pharmaceutical company

AusCann

Cannabinoids-based pharmaceutical company

Founded 2013 4 employees

General Information

Company Name AusCann
Founded Year 2013
Employees 4
Social

Get notified when AusCann moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AusCann

AusCann (ASX:AC8) is an Australian-based pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and internationally. AusCann transforms the way medicinal cannabis is dispensed today by making standardised, controlled dose products, providing educational support to healthcare professionals and generating clinical evidence that is accessible to patients, physicians and healthcare providers. AusCann is developing a pipeline of proprietary differentiated cannabinoid-based pharmaceutical products. The Company’s first product was successfully launched in Australia in 2020 and is available under special access provisions for medicines.

No funding data available for AusCann yet.

Get notified when AusCann raises funding

AusCann Alternatives & Competitors

AusCann vs
Savikalpa Sciences
Savikalpa Sciences India

Savikalpa Sciences is an R&D based healthcare company focused on cannabinoid life-sciences products....

18 employees
Health Care, Health and Wellness
AusCann vs
Gro-Vida
Gro-Vida Portugal

Global supplier of medical cannabis to the pharmaceutical industry

20 employees
Health Care, Manufacturing
AusCann vs
Althea Group Holdings (ASX:AGH)
Althea Group Holdings (ASX:AGH) Australia

AGH is a leader in the manufacturing, sales and distribution of cannabis-based medicines and consume...

23 employees
Manufacturing, Pharmaceutical

FAQ About AusCann

Cannabinoids-based pharmaceutical company
AusCann was founded in 2013.
AusCann has approximately 4 employees.
Top alternatives and competitors to AusCann include Savikalpa Sciences, Gro-Vida, Althea Group Holdings (ASX:AGH), MYCB1 Group B.V., GreenLight Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AusCann and Savikalpa Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AusCann and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy